Therapeutic Areas

Cardiovascular Disease Clinical Research

Reducing the burden of cardiovascular disease in patients

As a leading life-shortening disease, cardiovascular diseases are critical to prevent and treat immediately in patients around the world. The clinical trial process is complicated and full of unknowns.

Even the best cardiovascular therapeutic might not make it to the patients that need it, not because it does not work but because the design, data collection, and analysis were not done right.

Improving Cardiovascular Disease Outcomes Through Expertise

The acute nature of most cardiology/vascular diseases makes them highly complex to treat. Our diverse trial experience, coupled with our knowledgeable and experienced teams, allows us to confidently handle the most complex trials and patient populations with the attention and focus needed to navigate the cardiology/vascular disease landscape.

At Veristat, our experienced teams are poised to plan and implement these efforts quickly providing:

Development of regulatory strategy, expedited pathways, and regulatory agency interactions
Clinical program planning, inclusive of statistical planning and analysis
Agile patient recruitment strategies to support virtual trial and hybrid approaches
Rapid deployment of clinical trial databases
Virtual and remote clinical and medical site monitoring
Data analysis and migration into CDISC formats
Writing of clinical trial, safety, and regulatory documents
Preparation and defense of Marketing Applications – NDAs, BLAs, NDSs, MAAs, jNDAs, etc.


	100+ Projects supported for Cardiovascular Disorders
	>40% of these clinical trials are RARE DISORDERS
	100% of marketing applications prepared are approved, to date

100+

Projects supported for Cardiovascular Disorders

>40%

of these clinical trials are RARE DISORDERS

100%

of marketing applications prepared are approved, to date

Driving Successful Outcomes for Cardiovascular Trials
Abdominal Aortic Aneurysm (AAA)	Ehlers-Danlos Syndrome (EDS)	Ischemic Heart Disease
Acute Coronary Syndrome	Electrocardiogram (ECG)	Myocardial Infarction
Acute Hereditary Angioedema Attacks	Endocarditis	Pericarditis
Blood/Brain Barrier Crossing of Drug	Familial Chylomicronemia Syndrome (FCS)	Raynaud's Disease
Cardiac Fibrosis	Heart Failure	Stroke - Aneurysmal Subarachnoid Hemorrhage (aSAH)
Cardiac Imaging	Hereditary Transthyretin Amyloidosis (hATTR)	Treatment after Creation of Arteriovenous Access for Hemodialysis Use
Coronary Arterial Restenosis	Homozygous Familial Hypercholesterolemia (HoFH)	Vascular Access Graft
Coronary Artery Bypass Grafting (CABG)	Hyperlipoproteinemia(a) and Established Cardiovascular Disease (CVD)	Vascular Ehlers-Danlos Syndrome (EDS)
Coronary Artery Disease	Hypertension	Vascular Injury
Critical Limb Ischemia	Hypertriglyceridemia	Venous Leg Ulcers (VLU)